Sesen Bio (NASDAQ:SESN) stock is rising higher on Wednesday after revealing plans to meet with the U.S. Food and Drug Administration (FDA). Source: Shutterstock According to an 8-K filing with the U.S. Securities and Exchange Commission (SEC), Sesen Bio is taking part in a CMC Type A Meeting with the FDA on Oct. 29. This…

Sesen Bio (NASDAQ:SESN) is a small biotech company attempting to develop a drug it calls Vicineum. SESN stock plunged last month after hitting a massive regulatory setback. Source: luchschenF / Shutterstock.com Sesen’s Vicineum aims to treat unresponsive non-muscle invasive bladder cancer using a locally administered recombinant fusion protein method. However, the Food and Drug Administration…

Cambridge, Massachusetts-based cancer researcher Sesen Bio (NASDAQ:SESN) has had an action-packed August, to say the least. SESN stock has been a short-term trader’s paradise due to its volatility, but what do serious investors think? Source: Shutterstock First of all, volatility should be expected if you’re planning to hold low-priced biotechnology stocks. These stocks will move around…

Surgalign Holdings (NASDAQ:SRGA) stock is on the move Monday following news of the company’s CEO buying up shares of SRGA. Source: Shutterstock This news comes from filings with the U.S. Securities and Exchange Commission (SEC) on Friday. In that filing, we see that Terry Rich, president and CEO of Surgalign Holdings, went on a buying…

Thank goodness. The weekend is finally here and the major indices managed to once again close at record levels — despite the ominous undertones of Friday the 13th. So before you log off to dream of a sunny day spent on a yacht, what did the stock market do today? Source: Shutterstock The S&P 500…

Investors in Sesen Bio (NASDAQ:SESN) are certainly disappointed today. The biotech company is sharing some bad news with investors today, as the Food and Drug Administration (FDA) shoots down the company’s newest cutting-edge therapeutic. SESN stock is seeing a significant downturn in the midst of this rejection. Source: Shutterstock Sesen Bio is a small cap…

Today, investors in Sesen Bio (NASDAQ:SESN) are up big. Indeed, shares of SESN stock gained more than 22% today on a very green day for biotech stocks. Source: Shutterstock This maker of treatments for a specific type of bladder cancer has seen a tremendous amount of interest build in recent months. In fact, since the beginning of…